AMAG Pharmaceuticals reports first quarter 2016 financial results
AMAG Pharmaceuticals reported a net loss of $7.5 million for the 2016 first quarter versus net income of $12.9 million for the same 2015 period. Total revenues for the 2016 first quarter were $109.3 million versus $89.5 million in the same 2015 quarter. May 03, 2016